CG
NVO icon

Curat Global’s Novo Nordisk NVO Stock Holding History

Curat Global’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$145K Hold
3,830
– – 0.12% 105
2026
Q2 		$184K Hold
3,830
– – 0.15% 99
2026
Q1 		$141K Hold
3,830
– – 0.14% 108
2025
Q4 		$195K Hold
3,830
– – 0.22% 94
2025
Q3 		$213K Hold
3,830
– – 0.2% 95
2025
Q2 		$264K Hold
3,830
– – 0.25% 87
2025
Q1 		$266K Buy
+3,830
New +$316K 0.32% 84

Other funds holding NVO

Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Everett Harris & Co
Everett Harris & Co Los Angeles, California $8.46B AUM 13.48% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Saratoga Research & Investment Management
Saratoga Research & Investment Management Saratoga, California $1.82B AUM 11.8% 1-Year Est. Return
Markel Group
Markel Group Glen Allen, Virginia $12.8B AUM 8.77% 1-Year Est. Return
Natixis
Natixis Paris, France $28B AUM 27.03% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Oppenheimer Asset Management
Oppenheimer Asset Management New York $9.5B AUM 23.46% 1-Year Est. Return

Curat Global's NVO Position: Q3 2026 in Review

Curat Global held its Novo Nordisk (NVO) position steady in Q3 2026 at 3,830 shares worth $145K. The position accounts for 0.12% of the portfolio, ranked #105.

Curat Global first reported a position in NVO in Q1 2025 and has held it in 7 quarters since. The position peaked at $266K in Q1 2025. 696 funds tracked by Wall St. Rank hold NVO as of Q3 2026.

  • Curat Global held 3,830 shares of Novo Nordisk worth $145K as of Q3 2026.
  • Curat Global left its Novo Nordisk share count unchanged in Q3 2026.
  • Novo Nordisk made up 0.12% of Curat Global's portfolio in Q3 2026, its #105 holding.
  • Curat Global first reported a position in Novo Nordisk in Q1 2025 and has held it in 7 quarters since.
  • Curat Global's Novo Nordisk position peaked at $266K in Q1 2025.
  • 696 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.

Based on Curat Global's 13F filing for Q3 2026, filed 26 Oct 2026.